A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
Studies exploring metformin’s power to prevent prostate cancer progression have been inconclusive. Columbia research now shows that the drug has promise, but only for specific patients.
Larisa Geskin's first lobbying success led New York state to prohibit indoor tanning for children. Now she's urging Medicaid to help low-income families access sunscreen.
Many women and their physicians stick to annual Pap and HPV tests, Columbia researchers have found, despite new guidelines recommending less frequent cervical cancer screening.
Columbia cancer researchers are testing a new chemotherapy regimen for patients with an invasive form of bladder cancer who have limited options beyond radical surgery if initial treatment fails.
Newly identified immune cells infiltrate tumors in patients with localized kidney cancer and may be driving the cancer’s recurrence, Columbia researchers have found.
Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
Columbia cancer researchers are working to increase the representation of people of color in cancer clinical trials and decrease the health equity gap, with the help of Stand Up to Cancer.
Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients.
Using a new technique that uncovers the hidden tricks cancer cells use to resist immunotherapy, Columbia and MIT researchers have discovered why some melanoma patients do not respond to the therapy.